Figure 4.
Isobolographic analysis of the antiproliferative activity of the 1:1 and 1:2 [Ti(Def)2]2–/cisplatin combinations against Jurkat cells for 48 h.
Isobolographic analysis of the antiproliferative activity of the 1:1 and 1:2 [Ti(Def)2]2–/cisplatin combinations against Jurkat cells for 48 h.